M. Lorenz

1.5k total citations
52 papers, 1.1k citations indexed

About

M. Lorenz is a scholar working on Hematology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, M. Lorenz has authored 52 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 11 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Surgery. Recurrent topics in M. Lorenz's work include Blood Coagulation and Thrombosis Mechanisms (10 papers), Diabetes Treatment and Management (9 papers) and Blood properties and coagulation (3 papers). M. Lorenz is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (10 papers), Diabetes Treatment and Management (9 papers) and Blood properties and coagulation (3 papers). M. Lorenz collaborates with scholars based in Germany, United States and France. M. Lorenz's co-authors include Michael Wagner, Andreas Evers, M. R. Gaab, Hans E. Heissler, Volker Laux, Herman Schreuder, Michael Horowitz, Hartmut Rütten, Peter Ruus and R. H. A. Becker and has published in prestigious journals such as The Lancet, Blood and Analytical Biochemistry.

In The Last Decade

M. Lorenz

50 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Lorenz Germany 17 436 405 265 140 130 52 1.1k
Jeffrey W. Meeusen United States 21 223 0.5× 347 0.9× 295 1.1× 55 0.4× 47 0.4× 62 1.2k
Sarah R. Bujac United Kingdom 15 161 0.4× 248 0.6× 246 0.9× 59 0.4× 45 0.3× 18 930
Kazuhiko Sakaguchi Japan 23 552 1.3× 642 1.6× 377 1.4× 23 0.2× 84 0.6× 94 1.7k
Timothy Mant United Kingdom 20 74 0.2× 394 1.0× 393 1.5× 214 1.5× 35 0.3× 42 1.6k
Karen Smirnakis United States 15 137 0.3× 219 0.5× 350 1.3× 29 0.2× 151 1.2× 38 1.6k
Hideki Doi Japan 22 488 1.1× 693 1.7× 579 2.2× 31 0.2× 84 0.6× 48 2.0k
Lawrence de Garavilla United States 23 111 0.3× 432 1.1× 222 0.8× 367 2.6× 27 0.2× 62 1.7k
Jens Standop Germany 23 101 0.2× 599 1.5× 561 2.1× 38 0.3× 106 0.8× 65 1.7k
Sudesh K. Sood Canada 18 73 0.2× 589 1.5× 309 1.2× 99 0.7× 171 1.3× 27 2.0k
Wei Xu China 24 176 0.4× 740 1.8× 257 1.0× 20 0.1× 85 0.7× 152 1.9k

Countries citing papers authored by M. Lorenz

Since Specialization
Citations

This map shows the geographic impact of M. Lorenz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Lorenz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Lorenz more than expected).

Fields of papers citing papers by M. Lorenz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Lorenz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Lorenz. The network helps show where M. Lorenz may publish in the future.

Co-authorship network of co-authors of M. Lorenz

This figure shows the co-authorship network connecting the top 25 collaborators of M. Lorenz. A scholar is included among the top collaborators of M. Lorenz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Lorenz. M. Lorenz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elvert, Ralf, Andreas W. Herling, Martin Bossart, et al.. (2018). Running on mixed fuel‐dual agonistic approach of GLP‐1 and GCG receptors leads to beneficial impact on body weight and blood glucose control: A comparative study between mice and non‐human primates. Diabetes Obesity and Metabolism. 20(8). 1836–1851. 30 indexed citations
2.
Lorenz, M., et al.. (2013). Effects of lixisenatide once daily on gastric emptying in type 2 diabetes — Relationship to postprandial glycemia. Regulatory Peptides. 185. 1–8. 122 indexed citations
3.
Krauss, Joachim K., et al.. (2012). Surgical Treatment of Anterior Sacral Meningoceles in Patients with Marfan Syndrome. JBJS Case Connector. 2(2). e16–e16.
4.
Corbier, Alain, et al.. (2011). Oversulfated Chondroitin Sulfate and OSCS-Contaminated Heparin Cause Dose- and Route-Dependent Hemodynamic Effects in the Rat. Toxicological Sciences. 121(2). 417–427. 14 indexed citations
5.
Müller, F. Max, M. Lorenz, Wolfgang Tilgen, & Knuth Rass. (2010). Primary manifestation of erythema gyratum repens as a transient erythroderma in a patient with bronchial carcinoma. International Journal of Dermatology. 49(6). 676–678. 8 indexed citations
6.
Nakamura, Makoto, et al.. (2010). An errant bowel. The Lancet. 376(9746). 1116–1116. 1 indexed citations
7.
Lorenz, M., Winfried März, Emmanuelle Cousin, et al.. (2010). Association between the Thr325Ile polymorphism of the thrombinactivatable fibrinolysis inhibitor and stroke in the Ludwigshafen Risk and Cardiovascular Health Study. Thrombosis and Haemostasis. 103(5). 976–983. 16 indexed citations
8.
Lorenz, M., et al.. (2005). Anaemia after renal transplantation. European Journal of Clinical Investigation. 35(s3). 89–94. 13 indexed citations
9.
Nazaré, Marc, David W. Will, Hans Matter, et al.. (2004). Factor Xa inhibitors based on a 2-carboxyindole scaffold: SAR of neutral P1 substituents. Bioorganic & Medicinal Chemistry Letters. 14(16). 4191–4195. 13 indexed citations
10.
Frank, Michael, Sabine Maier, Harald K. Rau, et al.. (2004). Custom chemical microarray production and affinity fingerprinting for the S1 pocket of factor VIIa. Analytical Biochemistry. 335(1). 50–57. 17 indexed citations
11.
Klingler, Otmar, Hans Matter, Manfred Schudok, et al.. (2004). Structure-based design of amidinophenylurea-derivatives for factor VIIa inhibition. Bioorganic & Medicinal Chemistry Letters. 14(14). 3715–3720. 15 indexed citations
12.
Nazaré, Marc, Hans Matter, Otmar Klingler, et al.. (2004). Novel factor Xa inhibitors based on a benzoic acid scaffold and incorporating a neutral P1 ligand. Bioorganic & Medicinal Chemistry Letters. 14(11). 2801–2805. 11 indexed citations
13.
Nazaré, Marc, David W. Will, Hans Matter, et al.. (2004). Novel factor Xa inhibitors based on a 2-carboxyindole scaffold: SAR of P4 substituents in combination with a neutral P1 ligand. Bioorganic & Medicinal Chemistry Letters. 14(16). 4197–4201. 14 indexed citations
14.
Lorenz, M., et al.. (2003). Accumulation of radiolabelled platelets and fibrin on the carotid artery of rabbits after angioplasty: effects of heparin and dipyridamole. Thrombosis and Haemostasis. 90(12). 1179–1186. 16 indexed citations
15.
Klingler, Otmar, Hans Matter, Manfred Schudok, et al.. (2003). Design, synthesis, and structure–activity relationship of a new class of amidinophenylurea-based factor VIIa inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(8). 1463–1467. 23 indexed citations
16.
Rollnik, Jens D., Almuth Brandis, K. Dehghani, et al.. (2001). Die primäre Angiitis des ZNS (PACNS). Der Nervenarzt. 72(10). 798–801. 4 indexed citations
17.
Mäurer, J., et al.. (1999). Prospektive Studie zum Nachweis von Läsionen des Labrum glenoidale mit der indirekten MR-Arthrographie der Schulter*. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 171(Bd.2/4). 307–312. 8 indexed citations
18.
Lorenz, M. & J. R. Kalden. (1998). Biological Agents in Rheumatoid Arthritis. BioDrugs. 9(4). 303–324. 5 indexed citations
19.
Lorenz, M., et al.. (1998). High Doses of Methylene Blue/Light Treatment Crosslink the A-Alpha-Subunit of Fibrinogen: Influence of This Photooxidization on Fibrinogen Binding to Platelets. Pathophysiology of Haemostasis and Thrombosis. 28(1). 17–24. 14 indexed citations
20.
Lorenz, M., et al.. (1991). Effects of 33% stable xenon/O2mixture on somatosensory evoked potentials. Neurological Research. 13(2). 133–135. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey W. Meeusen Breakdown of academic impact, for papers by Sarah R. Bujac Breakdown of academic impact, for papers by Kazuhiko Sakaguchi Breakdown of academic impact, for papers by Timothy Mant Breakdown of academic impact, for papers by Karen Smirnakis Breakdown of academic impact, for papers by Hideki Doi Breakdown of academic impact, for papers by Lawrence de Garavilla Breakdown of academic impact, for papers by Jens Standop Breakdown of academic impact, for papers by Sudesh K. Sood Breakdown of academic impact, for papers by Wei Xu
Rankless by CCL
2026